The treatment of NSCLC brain metastases

被引：0

作者：

Noel-Savina, E. ^{[1
]}

Descourt, R. ^{[1
]}

Le Fur, E. ^{[2
]}

Robinet, G. ^{[1
]}

机构：

[1] CHU Brest, Unite Oncol Thorac, Inst Cancerol & Hematol, F-29200 Brest, France

[2] CHU Brest, Serv Radiotherapie, Inst Cancerol & Hematol, F-29200 Brest, France

来源：

ONCOLOGIE | 2012年 / 14卷 / 05期

关键词：

Lung cancer; Brain metastasis; Treatment; Surgery; Radiosurgery; Radiotherapy; Chemotherapy; CELL LUNG-CANCER; RADIATION-THERAPY; RANDOMIZED-TRIAL; STEREOTACTIC RADIOSURGERY; PHASE-III; SINGLE METASTASES; RADIOTHERAPY; CHEMOTHERAPY; MANAGEMENT; CISPLATIN;

D O I：

10.1007/s10269-012-2157-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Brain metastasis is a very common complication of lung cancer. Therapeutic methods include surgery, radiotherapy, and systemic therapies including chemotherapy and molecular therapies. The main question is the most relevant use of these therapies, which is still not determined. It depends on many factors such as the control of the lung disease, the patient's general state, and the number ofmetastases. As a result, the decision needs a coordinated and multidisciplinary team approach.

引用

页码：305 / 309

页数：5

共 26 条

[1] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].

Andrews, DW ;

Scott, CB ;

Sperduto, PW ;

Flanders, AE ;

Gaspar, LE ;

Schell, MC ;

Werner-Wasik, M ;

Demas, W ;

Ryu, J ;

Bahary, JP ;

Souhami, L ;

Rotman, M ;

Mehta, MP ;

Curran, WJ .

LANCET, 2004, 363 (9422) :1665-1672

[2] Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial [J].

Aoyama, Hidefumi ;

Shirato, Hiroki ;

Tago, Masao ;

Nakagawa, Keiichi ;

Toyoda, Tatsuya ;

Hatano, Kazuo ;

Kenjyo, Masahiro ;

Oya, Natsuo ;

Hirota, Saeko ;

Shioura, Hiroki ;

Kunieda, Etsuo ;

Inomata, Taisuke ;

Hayakawa, Kazushige ;

Katoh, Norio ;

Kobashi, Gen .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2483-2491

[3] Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01) [J].

Barlesi, F. ;

Gervais, R. ;

Lena, H. ;

Hureaux, J. ;

Berard, H. ;

Paillotin, D. ;

Bota, S. ;

Monnet, I. ;

Chajara, A. ;

Robinet, G. .

ANNALS OF ONCOLOGY, 2011, 22 (11) :2466-2470

[4] Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial [J].

Chang, Eric L. ;

Wefel, Jeffrey S. ;

Hess, Kenneth R. ;

Allen, Pamela K. ;

Lang, Frederick F. ;

Kornguth, David G. ;

Arbuckle, Rebecca B. ;

Swint, J. Michael ;

Shiu, Almon S. ;

Maor, Moshe H. ;

Meyers, Christina A. .

LANCET ONCOLOGY, 2009, 10 (11) :1037-1044

[5] Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer [J].

Edelman, Martin J. ;

Belani, Chandra P. ;

Socinski, Mark A. ;

Ansari, Rafat H. ;

Obasaju, Coleman K. ;

Chen, Ruqin ;

Monberg, Matthew J. ;

Treat, Joseph .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (01) :110-116

[6] Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials [J].

Gaspar, L ;

Scott, C ;

Rotman, M ;

Asbell, S ;

Phillips, T ;

Wasserman, T ;

McKenna, WG ;

Byhardt, R .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04) :745-751

[7] Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non-Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214 [J].

Gore, Elizabeth M. ;

Bae, Kyounghwa ;

Wong, Stuart J. ;

Sun, Alexander ;

Bonner, James A. ;

Schild, Steven E. ;

Gaspar, Laurie E. ;

Bogart, Jeffery A. ;

Werner-Wasik, Maria ;

Choy, Hak .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (03) :272-278

[8] Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer [J].

Hotta, K ;

Kiura, K ;

Ueoka, H ;

Tabata, M ;

Fujiwara, K ;

Kozuki, T ;

Okada, T ;

Hisamoto, A ;

Tanimoto, M .

LUNG CANCER, 2004, 46 (02) :255-261

[9] Whole-brain radiotherapy in the management of brain metastasis [J].

Khuntia, D ;

Brown, P ;

Li, J ;

Mehta, MP .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) :1295-1304

[10] Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study [J].

Kocher, Martin ;

Soffietti, Riccardo ;

Abacioglu, Ufuk ;

Villa, Salvador ;

Fauchon, Francois ;

Baumert, Brigitta G. ;

Fariselli, Laura ;

Tzuk-Shina, Tzahala ;

Kortmann, Rolf-Dieter ;

Carrie, Christian ;

Ben Hassel, Mohamed ;

Kouri, Mauri ;

Valeinis, Egils ;

van den Berge, Dirk ;

Collette, Sandra ;

Collette, Laurence ;

Mueller, Rolf-Peter .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) :134-141

← 1 2 3 →